Skip to main content
Annals of Tropical Medicine and Parasitology logoLink to Annals of Tropical Medicine and Parasitology
. 2011 Jan;105(1):47–56. doi: 10.1179/136485911X12899838413420

Hospitalization of Cuban children for giardiasis: a retrospective study in a paediatric hospital in Havana

A A Escobedo *, P Almirall , M Alfonso , Y Salazar , I Ávila §, S Cimerman , F A Núñez **, I V Dawkins §
PMCID: PMC4089796  PMID: 21294948

Abstract

The medical records of the 185 children who, in 2007, were admitted to the Academic Paediatric Hospital ‘Centro Habana’, in the Cuban capital of Havana, because of giardiasis were analysed retrospectively. A standardized form was used to collect data on the socio–demographic characteristics, clinical features, laboratory diagnosis, treatment and length of stay of each child. Information on the 15 children who had incomplete medical records was excluded from the data analysis. Of the remaining 170 children, 85 (50.0%) were aged 1–4 years, 97 (57.1%) were male, and 106 (62.4%), 92 (54.1%) and 69 (40.6%) had presented with diarrhoea, vomiting, and/or abdominal pain, respectively. Most (91.2%) of the cases had been diagnosed by the microscopical examination of a duodenal aspirate, and the drugs that had been most used frequently were quinacrine and tinidazole, which had been given to 72 (42.4%) and 62 (36.5%) of the cases, respectively. The mean length of hospital stay was 4.9 days. Such information on the clinical characteristics of giardiasis among children living in an endemic area may be valuable to paediatricians and public-health officials who wish to screen for the disease.


Giardia lamblia (synonymous with Giardia duodenalis and Giardia intestinalis) remains one of the commonest pathogenic protozoans to be found in the human intestinal tract. In many developed countries, where the pathogen appears to be increasingly involved in diarrhoeal disease in day-care centres and water-associated outbreaks elsewhere, giardiasis is considered to be a re-emerging disease (Thompson, 2000). Despite its generally high prevalence in developing countries, giardiasis often has a very focal distribution. The disease has been included in the ‘Neglected Diseases Initiative’ since 2004 (Savioli et al., 2006).

In developing countries, G. lamblia infections are particularly common among children and pose a serious threat to child health and development, even though most infections with this protozoan are either asymptomatic or only involve a non-specific, mild and self-resolving illness. Unfortunately, some cases develop severe diarrhoea (with or without malabsorption syndrome), nausea, vomiting, weight loss (Escobedo et al., 2010) and/or poor cognitive function and failure to thrive in early childhood (Berkman et al., 2002). Recently, G. lamblia has also been implicated in post-infectious irritable bowel syndrome (Hanevik et al., 2009) and chronic fatigue (Mørch et al., 2009).

Although Giardia infection is relatively easy to diagnose and is curable, even with a single oral dose of an antiparasitic drug, its early detection and treatment form an important component of efforts to reduce transmission, the associated disease burden, and the risks of an infected individual developing chronic or intermittent symptoms (Escobedo et al., 2010).

Many scientific questions about giardiasis remain unanswered, and the scientific world is only now attempting to catch up on decades of relative neglect. Our knowledge of the risk factors for, and clinical manifestations of, human giardiasis comes largely from studies either on travellers returning from countries where the disease is highly endemic or on major outbreaks. Surprisingly little is known about hospitalizations for the disease — or the clinical features of those hospitalized — in endemic countries, although hospital-admission data may form a valuable tool for assessing the epidemiology of a disease within a given population. The focus of the present study was on the clinical significance of giardiasis in Cuban children who had been hospitalized (presumably) because of the disease.

PATIENTS AND METHODS

Study Design and Setting

This retrospective study reviewed the records of those children who were admitted, with a diagnosis of giardiasis, to the Academic Paediatric Hospital ‘Centro Habana’ (APHCH), in Havana, Cuba, on any day in 2007. The 226-bed study hospital, which is a government-funded and public facility, has already been chosen for several epidemiological studies because of the well-defined population that it serves (unpubl. obs.). It provides secondary and tertiary care and active ambulatory and emergency services, within all clinical and surgical specialities, for children from all over Cuba but mainly for children from the Centro Habana, Plaza, Cerro and Habana Vieja municipalities.

Data Collection

The staff in the APHCH's medical-records department was asked to provide a list (including the corresponding hospital registration number for each patient) of all the patients admitted in 2007 who had giardiasis (coded as A07-1) listed among their discharge diagnoses. The registration numbers were then used to obtain all the data held, as paper files, by the medical-records department, on each patient of interest. The files of interest were stored in the records department, for retrieval whenever needed.

Patients were only included in the study if: (1) their records appeared to be complete; (2) their symptoms recorded at presentation were consistent with giardiasis; and (3) Giardia cysts and/or trophozoites had been seen, by microscopy, in at least one faecal specimen or duodenal aspirate from the patient. For patients who had been admitted more than once in 2007, two admissions within a fortnight were considered to be a single admission.

The medical records of each patient who met all the inclusion criteria were studied in detail, with his or her socio–demographic characteristics (i.e., gender, age and address), medical history (i.e. date of admission, presenting signs and symptoms, and any co-diagnoses), laboratory results (i.e. results of the examinations of faecal samples and/or duodenal aspirates), prescribed treatment for giardiasis, and length of hospital stay all transferred to a standardized data-collection form.

Data Analysis

The data were analysed using version 6.04 of the Epi InfoTM software package (Centers for Disease Control and Prevention, Atlanta, GA), with χ2 and Fisher's exact tests used, as appropriate, to make inter-group comparisons. A P-value of <0.05 was considered indicative of a statistically significant difference.

Ethical Considerations

The study protocol was approved by the APHCH's Ethics for Research Committee, on the condition that the authors maintained the confidentiality of the data retrieved from the patients' clinical records. Although four of the authors (A.A.E., P.A., M.A. and Y.S.) worked directly with the records, the names of the patients were excluded from the database used for the statistical analysis. Since the investigation was retrospective and based entirely on the results of the routine investigation of the patients by the staff of the APHCH, informed consent was not obtained specifically for the purposes of the present study.

RESULTS

Characteristics of the Study Population

During the study period, 8469 children were admitted to the APHCH, 1012 (11.9%) of them because of diarrhoea and 185 (2.2%) because of (parasitologically confirmed) giardiasis. Of the 185 cases of giardiasis admitted in 2007, 15 had incomplete medical records (nine) or missing medical records (six) at the time of the present study and were excluded from the data analysis. Of the 170 cases of giardiasis included in the final analysis (see Table), 97 (57.1%) were boys and 73 (42.9%) were girls (P<0.01). Thirty-seven (21.8%), 85 (50.0%), 42 (24.7%) and six (3.5%) of these cases were aged <1 year, 1–4 years, 5–12 years and >12 years, respectively.

Characteristics of the 170 patients with complete clinical records who, in 2007, were admitted to the Academic Paediatric Hospital ‘Centro Habana’ with Giardia infection.

Characteristic No. and (%) of patients
gender
 Male 97 (57.1)
 Female 73 (42.9)
age (years)
 <1 37 (21.8)
 1–4 85 (50.0)
 5–12 42 (24.7)
 >12 6 (3.5)
length of hospital stay (days)
 <2 1 (0.6)
 2–4 89 (52.4)
 >4 80 (47.1)
clinical features
 Diarrhoea 106 (62.4)
 Vomiting 92 (54.1)
 Abdominal pain 69 (40.6)
 Fever (⩾38°C) 39 (23.1)
 Weakness 25 (14.7)
 Dehydration 20 (11.8)
 Poor oral intake 18 (10.6)
 Weight loss 6 (3.5)
 Urticaria 5 (2.9)
method used to confirm giardiasis
 Examination of duodenal aspirate 155 (91.2)
 Examination of faecal sample(s) 15 (8.8)
chemotherapy
 Quinacrine 72 (42.4)
 Tinidazole 62 (36.5)
 Secnidazole 28 (16.4)
 Metronidazole 8 (4.7)

Clinical Profile

At presentation (see Table), the commonest complaint was diarrhoea [seen in 106 (62.4%) of the 170 cases] followed by vomiting [92 (54.1%)] and abdominal pain [69 (40.6%)]. Urticaria, an unusual manifestation of giardiasis, was present in five of the cases (Table). No common source of the 170 giardial infections was identified.

Laboratory Evaluation

Giardiasis was confirmed by the results of the microscopic examination of either duodenal fluid [155 (91.2%) of the cases] or faecal samples [15 (8.8%) of the cases]. Only one or two faecal specimens had been requested from most of the cases (data not shown).

Treatment and Length of Stay

Antigiardial treatment (quinacrine, tinidazole, secnidazole or metronidazole) was given to all 170 cases (see Table), with quinacrine [72 (42.4%) of the cases] and tinidazole [62 (36.5%)] the drugs that were most frequently prescribed. The mean length of hospital stay was 4.9 days (range = 1–16 days).

DISCUSSION

Although, in general, the prevalence of human infection with intestinal parasites has declined significantly in Cuba over the last few decades, infections with intestinal protozoa, especially G. lamblia, remain among the most common infections diagnosed (Rojas et al., 2008). According to the last national survey, the overall prevalence of Giardia infection in the human population is about 7.2% (E. Sanjurjo, unpubl. obs.); although the evidence to support this belief seems largely anecdotal, clinical giardiasis is generally considered to be an important public-health problem in Cuba, placing a large burden on both diagnostic and treatment services in the country's healthcare institutions. Higher prevalences have been recorded among young children attending day-care centres and primary schools in Cuba (Núñez et al., 1999; Arencibia et al., 2001; Mendoza et al., 2001; Escobedo et al., 2007). Among young children, a lack of faecal continence before toilet training, frequent person–person and hand–mouth contact, poor standards of hygiene, an immature immune system and the high probability that any Giardia infection will be a primary infection presumably combine to increase the probabilities of both Giardia infection and symptomatic giardiasis (Rojas et al., 2008). In endemic areas, the incidence of giardiasis tends to peak in children aged 2–3 years and then to decrease with increasing age, perhaps as the result of acquired immunity (Núñez et al., 1999) and/or improving standards of hygiene. In a community-based study conducted in the Cuban province of Pinar del Río, Escobedo et al. (2008b) found children aged <6 years to be at a more than 3-fold higher risk of Giardia infection than children aged 6–10 years. Elsewhere in Cuba (Núñez et al., 1999) and in Kenya (Chunge et al., 1991), Israel (Fraser et al., 1997), Brazil (Pereira et al., 2007) and New Zealand (Snel et al., 2009), relatively high risks of G. lamblia infection have been detected in children, at least after the first year of life.

In the present study, significantly more of the giardiasis cases identified were boys than girls. A similar predominance of males was seen by Keiser et al. (2002), in a community-based study in Côte d'Ivoire, where the prevalence of Giardia infections among the male participants was found to be double that among the female. In Giardia surveillance in the U.S.A. (Yoder and Beach, 2007), male cases have been found to outnumber the female in every age-group considered except the youngest (<1 year) and the eldest (>59 years). A male predominance among giardiasis cases has also been reported in Ontario, Canada (Greig et al., 2001). Such a gender bias has not, however, been seen everywhere. The boys attending the Cuban day-care centres investigated by Núñez et al. (1999), for example, were found to be no less or more likely to harbour Giardia infection than their female playmates. These divergent results could be a consequence of gender-associated differences in exposure to Giardia (with the behaviour and recreational exposure of boys differing from those of girls in some settings) and/or gender-associated differences in susceptibility to infection post-exposure. Sex-associated hormones may modulate the immune responses of a mammalian host and thus directly influence the outcome of parasite infection (Roberts et al., 2001). The possibility that females are, in general, better protected against giardial infection and/or the development of symptomatic giardiasis than their male counterparts deserves further investigation.

The clinical manifestations of giardiasis are extremely variable and may overlap with those of a wide range of infectious and non-infectious gastro-intestinal disorders. Most of the cases of the disease investigated in the present study presented with diarrhoea. This common feature of symptomatic giardiasis (Pereira et al., 2007; Dib et al., 2008; El Guamri et al., 2009) may be characteristic of acute infection and is often short-lived and self-limiting, although it may become chronic. In Cuba, unfortunately, little is known about the infectious agents affecting hospitalized patients with diarrhoea. Of the hospitalized children investigated by Núñez et al. (2003), in another paediatric hospital in Havana, 9% were found infected with Giardia, including 5% of the children with diarrhoea. In similar studies in Greece (Kafetzis et al., 2001) and India (Saha et al., 2008), the prevalence of Giardia infection among hospitalized children with diarrhoea has been found to be relatively low.

Abdominal pain is also frequently reported in symptomatic patients with giardiasis (Aparicio Tijeras et al., 2004). In their recent observational study in Peshawar, Pakistan, Younas et al. (2008) detected Giardia infection in 74 (31%) of 239 children with recurrent abdominal pain. When Yakoob et al. (2005) investigated dyspeptic patients who attended the gastro-enterology department of the Aga Khan University Hospital in Karachi, Pakistan, they found that 68 (71%) of the 96 patients with giardiasis complained of abdominal pain (P = 0.02) and that 28 (29%) of the giardiasis cases had diarrhoea (P = 0.005). Concomitant Giardia and Helicobacter pylori infections may often play an important role in the development of recurrent abdominal pain in children (Zeyrek et al., 2008). Compared with the healthy children used as controls, Turkish children with recurrent abdominal pain were not found significantly more likely to be infected with H. pylori or Giardia but they were found significantly more likely to be co-infected with the two pathogens (22.4% v. 6.8%; P = 0.002; Zeyrek et al., 2008).

Although the possible association between Giardia infection and some allergic manifestations has already been discussed (Veronesi et al., 1983; Nenoff et al., 2006), the discovery that five giardiasis cases investigated in the present study had urticaria was a surprise. The subjects of the present study, had, however, all been hospitalized and therefore generally represented children with relatively severe giardiasis, among whom urticaria may be relatively common. In diarrhoeal patients in general, the impaired function of the gastro-duodenal barrier may increase the possibility of chronic urticaria (Buhner et al., 2004). In immunocompetent but athymic mice, Giardia infection caused a significant increase in small intestinal (but not gastric or colonic) permeability that correlated with trophozoite colonization (Scott et al., 2002). In humans, damage to the intestinal wall resulting from Giardia infection may also increase intestinal permeability (Dagci et al., 2002). In Cuba, high prevalences of Giardia infection have been seen among patients with urticarial vasculitis (Martínez-Rodríguez et al., 1992). In the present study, however, the observed urticaria cannot be unequivocally attributed to Giardia infection, as the aetiology of this allergic disturbance might lie in other concomitant and missed diagnoses.

None of the children included in the present study was recorded as having acute or chronic malnutrition and <15% were recorded as having dehydration, even though malnutrition and dehydration have been found to be common features of paediatric giardiasis in many other settings (Adam, 2001). In Cuba, however, access to hospitals is relatively easy and free of charge, so children tend to receive medical care before such complications develop.

The easy availability of duodenal aspiration in the hospital at which the present study was based appears to have resulted in an over-reliance on duodenal aspirates for the diagnosis of giardiasis. Almost all of the children included in the present study had been confirmed as giardiasis cases by the microscopical examination of such aspirates, even when it remains unclear whether this method is more (Kamath and Murugasu, 1974; Rosenthal and Liebman, 1980) or less sensitive (Goka et al., 1990) than the examination of faecal samples (which is non-invasive and remains the standard procedure for most intestinal parasites). The examination of wet mounts of unconcentrated samples may offer generally low sensitivity but the APHCH lacked the facilities needed for sample concentration (such as formalin–ether or Faust flotation) in 2007. Sample concentration would increase sensitivity without much extra input. Despite slightly increasing the time needed for a diagnosis, it is simple and can be applied easily in a laboratory with quite basic equipment and staff training.

The examination of a single faecal specimen/patient is generally considered insufficient for the diagnosis of giardiasis (Hiatt et al., 1995) because the shedding of Giardia cysts or trophozoites is often intermittent or at such low levels that it is difficult to detect (Hiatt et al., 1995; Cartwright, 1999). Ideally, a duodenal aspirate should be collected from a suspected case of giardiasis who has been found Giardia-negative over the recommended three faecal examinations (Wolfe, 1992), and checked for Giardia. The routine use of duodenal aspiration as the initial method for the detection of a Giardia infection cannot be recommended even though, at the APHCH in 2007, it made diagnosis quicker (than the examination of multiple faecal samples/patient) and therefore, presumably, generally reduced the length of each giardiasis case's hospital stay.

In the present study, the Giardia-infected children were treated using one the four drug regimens (based on metronidazole, tinidazole, secnidazole or quinacrine) approved for giardiasis in the Cuban national therapeutic guidelines (Anon., 2006). Curiously, although these guidelines recommend the use of metronidazole for first-line treatment [the drug has been found to achieve parasitological cure in 75%–100% of giardiasis cases (Escobedo and Cimerman, 2007)], this drug was only used rarely to treat giardiasis cases at the APHCH in 2007. Quinacrine and tinidazole were the drugs most frequently used to treat giardiasis at the APHCH in 2007, probably simply because they were available at the time of the diagnoses and considered as effective as metronidazole (Escobedo et al., 2003; Cañete et al., 2006). Tinidazole is also slightly cheaper [U.S.$40/1000 children treated compared with U.S.$45/1000 for metronidazole (Chandy and McCarthy, 2009)], generally well tolerated, clears diarrhoea quickly (Gazder and Benerjee, 1978) and can be used to treat giardiasis as a single oral dose (Escobedo and Cimerman, 2007), which has the potential to improve compliance.

The length of hospital stay has many implications both for the patient and the public-health service. For the latter, these include impacts on financial resources, staffing and bed availability. Stay length has been repeatedly used as an indicator of efficiency in in-patient care. In the present study, the mean hospital stay of a giardiasis case was 4.9 days, comparable with the corresponding 4 days found in the U.S.A. (Lengerich et al., 1994) and the 3 days (overall mean) or 4 days (mean for cases aged <5 years) recorded in Scotland (Robertson, 1996). Cases may be discharged while still receiving chemotherapy (once they have shown a clinical response). The diarrhoea associated with giardiasis generally resolves a few days post-treatment (Ortiz et al., 2001; Rossignol et al., 2001), occasionally before parasitological cure has been achieved (Escobedo et al., 2008a).

No attempt was made to evaluate, in the present study, the financial costs of the hospitalization of children with giardiasis but such costs have been explored in some other investigations, with interesting results. Robertson (1996) estimated the annual hospitalization costs associated with severe giardiasis in Scotland to be in excess of £31,000 (about U.S.$50,000 in 1996) while, more recently, notified cases of human giardiasis in New Zealand were estimated to cost the health system N.Z.$987,000 (about U.S.$500,000) each year (Snel et al., 2009). The true economic costs of human giardiasis in Scotland and New Zealand are probably much higher than these two estimates indicate, however, since the estimates take no account of non-notified cases of the disease.

The present results need to be interpreted with caution, given the limitations of the study on which they are based. Firstly, the results are based on a retrospective review of medical records that may not be comprehensive. Secondly, a hospital-based study can only provide limited information about the prevalence of giardiasis in the general community, partly because children with giardiasis who present at a hospital are not likely to be representative of children with giardiasis in the general population, with many milder cases never presenting at a health facility or only seeking care from a general practitioner or a centre for primary healthcare. Thirdly, the diarrhoea episodes (and other symptoms) seen in many of the children investigated in the present study could not be unequivocally attributed to giardial infection, partly because the tests necessary to exclude other causes were often never conducted. The only cases to have faecal samples checked for bacterial pathogens, by culture, were those who were suspected clinically of having infections with such bacteria, and no attempt was made to check any child for viruses because the laboratory resources that were available were too limited. Finally, it was not possible to follow-up the children investigated after their hospital discharge and so assess either the development of ‘residual morbidity’ related to Giardia infection or the frequency of treatment failure. Despite these limitations, the present results provide valuable insight into the clinical manifestations of paediatric giardiasis in an endemic area, the age–prevalence relationship of the condition (at least among children), and the burden posed by giardiasis on in-patient services in Cuba. Although the data analysed are inevitably referral- and access-biased, they provide useful information on Giardia-related morbidity in the study area and the role played by hospital-based paediatric services in the management of giardiasis in Havana.

The present results may help physicians practising in endemic areas to diagnose cases of symptomatic giardiasis (particularly paediatric cases) promptly and accurately, although the general non-specificity of the signs and symptoms of this disease hamper its diagnosis. It is evident that, at the APHCH (and, presumably, many similar hospitals in Cuba), stronger efforts should be made to detect Giardia and/or other enteropathogens, partly by checking at least three faecal samples/patient.

Acknowledgments

The authors thank the staff of the APHCH's medical-records department for assisting with the data collection and supplying all the medical case files needed for the study.

REFERENCES

  • 1.Adam RD.(2001)The biology of Giardia. Clinical Microbiology Reviews 14447–475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Anon(2006)Centro para el Desarrollo de la Farmacoepidemiología. Formulario Nacional de Medicamentos. Havana: Editorial Ciencias Médicas [Google Scholar]
  • 3.Aparicio Tijeras C, Ezquerra-Gadea J, López-Larrayoz I, Sánchez-Ruiz JC.(2004)Dolor abdominal en infección por Giardia lamblia. Atención Primaria 34102–103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Arencibia AA, Escobedo AA, Núñez FA, Almirall P.(2001)Parásitos intestinales en niños que asisten a una escuela primaria urbana de Ciudad de la Habana. Boletín Epidemiológico del Instituto Pedro Kourí 1158–59. [Google Scholar]
  • 5.Berkman DS, Lescano AG, Gilman RH, Lopez SL, Black MM.(2002)Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in the late childhood: a follow-up study. Lancet 359564–571. [DOI] [PubMed] [Google Scholar]
  • 6.Buhner S, Reese I, Kuehl F, Lochs H, Zuberbier T.(2004)Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy 591118–1123. [DOI] [PubMed] [Google Scholar]
  • 7.Cañete R, Escobedo AA, González ME, Almirall P.(2006)Randomized clinical study of five days' therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children. World Journal of Gastroenterology 126366–6370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cartwright CP.(1999)Utility of multiple-stool-specimen ova and parasite examinations in a high-prevalence setting. Journal of Clinical Microbiology 372408–2411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chandy E, McCarthy J.(2009)Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate treatment for giardiasis? Journal of Tropical Pediatrics 555–7. [DOI] [PubMed] [Google Scholar]
  • 10.Chunge RN, Nagelkerke N, Karumba PN, Kaleli N, Wamwea M, Mutiso N, Andala EO, Gachoya J, Kiarie R, Kinoti SN.(1991)Longitudinal study of young children in Kenya: intestinal parasitic infection with special reference to Giardia lamblia, its prevalence, incidence and duration, and its association with diarrhoea and with other parasites. Acta Tropica 5039–49. [DOI] [PubMed] [Google Scholar]
  • 11.Dagci H, Ustun S, Taner MS, Rezos G, Karacasu F, Budak S.(2002)Protozoan infections and intestinal permeability. Acta Tropica 811–5. [DOI] [PubMed] [Google Scholar]
  • 12.Dib HH, Lu SQ, Wen SF.(2008)Prevalence of Giardia lamblia with or without diarrhea in South East, South East Asia and the Far East. Parasitology Research 103239–251. [DOI] [PubMed] [Google Scholar]
  • 13.El Guamri Y, Belghyti D, Achicha A, Tiabi M, Aujjar N, Barkia A, El Kharrim K, Barkia H, El-Fellaki E, Mousahel R, Bouachra H, Lakhal A.(2009)Enquête épidémiologique rétrospective sur les parasitoses intestinales au centre hospitalier provincial El Idrissi (Kénitra, Maroc): bilan de 10 ans (1996–2005). Annales de Biologie Clinique 67191–202. [DOI] [PubMed] [Google Scholar]
  • 14.Escobedo AA, Cimerman S.(2007)Giardiasis: a pharmacotherapy review. Expert Opinion in Pharmacotherapy 81885–1902. [DOI] [PubMed] [Google Scholar]
  • 15.Escobedo AA, Núñez FA, Moreira I, Vega E, Pareja A, Almirall P.(2003)Chloroquine and albendazole in the treatment of paediatric patients with giardiasis. Annals of Tropical Medicine and Parasitology 97367–371. [DOI] [PubMed] [Google Scholar]
  • 16.Escobedo AA, Cañete R, Núñez FA.(2007)Intestinal protozoan and helminth infections in the municipality San Juan y Martínez, Pinar del Río, Cuba. Tropical Doctor 37236–238. [DOI] [PubMed] [Google Scholar]
  • 17.Escobedo AA, Álvarez G, González ME, Almirall P, Cañete R, Cimerman S, Ruíz A, Pérez R.(2008a)The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Annals of Tropical Medicine and Parasitology 102199–207. [DOI] [PubMed] [Google Scholar]
  • 18.Escobedo AA, Cañete R, Núñez FA.(2008b)Prevalence, risk factors and clinical features associated with intestinal parasitic infections in children from San Juan y Martínez, Pinar del Río, Cuba. West Indian Medical Journal 57378–381. [PubMed] [Google Scholar]
  • 19.Escobedo AA, Almirall P, Robertson LJ, Franco RM, Hanevik K, Mørch K, Cimerman S.(2010)Giardiasis: the ever present threat of a neglected disease. Infectious Disorders — Drug Targets 10329–348. [DOI] [PubMed] [Google Scholar]
  • 20.Fraser D, Dagan R, Naggan L, Greene V, El-On J, Abu-Rbiah Y, Deckelbaum RJ.(1997)Natural history of Giardia lamblia and Cryptosporidium infections in a cohort of Israeli Bedouin infants: a study of a population in transition. American Journal of Tropical Medicine and Hygiene 57544–549. [DOI] [PubMed] [Google Scholar]
  • 21.Gazder AJ, Benerjee M.(1978)Single dose therapy of giardiasis with tinidazole and metronidazole. Drugs 15Suppl. 1, 30–32. [DOI] [PubMed] [Google Scholar]
  • 22.Goka AK, Rolston DD, Mathan VI, Farthing MJ.(1990)The relative merit of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 8466–67. [DOI] [PubMed] [Google Scholar]
  • 23.Greig JD, Michel P, Wilson JB, Lammerding AM, Majowicz SE, Stratton J, Aramini JJ, Meyers RK, Middleton D, McEwen SA.(2001)A descriptive analysis of giardiasis cases reported in Ontario 1990–1998. Canadian Journal of Public Health 92361–365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hanevik K, Dizdar V, Langeland N, Hausken T.(2009)Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterology 927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hiatt RA, Markell EK, Ng E.(1995)How many stool examinations are necessary to detect pathogenic intestinal protozoa? American Journal of Tropical Medicine and Hygiene 5336–39. [PubMed] [Google Scholar]
  • 26.Kafetzis DA, Maltezou HC, Zafeiropoulou A, Attilakos A, Stavrinadis C, Foustoukou M.(2001)Epidemiology, clinical course and impact on hospitalization costs of acute diarrhea among hospitalized children in Athens, Greece. Scandinavian Journal of Infectious Diseases 33681–685. [DOI] [PubMed] [Google Scholar]
  • 27.Kamath KR, Murugasu R.(1974)A comparative study of four methods for detecting Giardia lamblia in children with diarrheal disease and malabsorption. Gastroenterology 6616–21. [PubMed] [Google Scholar]
  • 28.Keiser J, N'Goran E, Traoré M, Lohourignon KL, Tanner M, Utzinger J.(2002)Polyparasitism with Schistosoma mansoni, geohelminths, and intestinal protozoa in rural Côte d'Ivoire. Journal of Parasitology 88461–466. [DOI] [PubMed] [Google Scholar]
  • 29.Lengerich EJ, Addiss DG, Juranek DD.(1994)Severe giardiasis in the United States. Clinical Infectious Diseases 18760–763. [DOI] [PubMed] [Google Scholar]
  • 30.Martínez-Rodríguez MI, Cantero-Zayas L, Alfonso-Fernández LA, Valdés-Sánchez AF, Gómez-Echevarría AH, Ochoa-Ochoa C, Chong-López A.(1992)Chronic urticaria: humoral and clinical diagnosis of its morphological variables. Journal of Investigational Allergology and Clinical Immunology 2126–130. [PubMed] [Google Scholar]
  • 31.Mendoza D, Núñez FA, Escobedo A, Pelayo L, Fernández M, Torres D, Cordoví RA.(2001)Parasitosis Intestinales en 4 círculos infantiles de San Miguel del Padrón, Ciudad de la Habana, 1998. Revista Cubana de Medina Tropical 53189–193. [PubMed] [Google Scholar]
  • 32.Mørch K, Hanevik K, Rortveit G, Wensaas KA, Langeland N.(2009)High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 103530–532. [DOI] [PubMed] [Google Scholar]
  • 33.Nenoff P, Domula E, Willing U, Herrmann J.(2006)Giardia lamblia — ursache von urtikaria und pruritus oder zufällige assoziation? Hautarzt 57518–520., 521–522. [DOI] [PubMed] [Google Scholar]
  • 34.Núñez FA, Hernández M, Finlay CM.(1999)Longitudinal study of giardiasis in three day care centres of Havana City. Acta Tropica 73237–242. [DOI] [PubMed] [Google Scholar]
  • 35.Núñez FA, González OM, Bravo JR, Escobedo AA, González I.(2003)Parasitosis intestinales en niños ingresados en el Hospital Universitario Pediátrico del Cerro, La Habana, Cuba. Revista Cubana de Medicina Tropical 5519–26. [PubMed] [Google Scholar]
  • 36.Ortiz JJ, Ayoub A, Gargala G, Chegne NL, Favennec L.(2001)Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru. Alimentary Pharmacology and Therapeutics 151409–1415. [DOI] [PubMed] [Google Scholar]
  • 37.Pereira MG, Atwill ER, Barbosa AP.(2007)Prevalence and associated risk factors for Giardia lamblia infection among children hospitalized for diarrhea in Goiânia, Goiás state, Brazil. Revista do Instituto de Medicina Tropical de São Paulo 49139–145. [DOI] [PubMed] [Google Scholar]
  • 38.Roberts CW, Walker W, Alexander J.(2001)Sex-associated hormones and immunity to protozoan parasites. Clinical Microbiology Reviews 14476–488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Robertson LJ.(1996)Severe giardiasis and cryptosporidiosis in Scotland, UK. Epidemiology and Infection 117551–561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rojas L, Núñez FA, Robertson LJ.(2008)Cuban parasitology in review: a revolutionary triumph. Trends in Parasitology 24440–448. [DOI] [PubMed] [Google Scholar]
  • 41.Rosenthal P, Liebman WM.(1980)Comparative stool examinations, duodenal aspiration, and pediatric enterotest for giardiasis in children. Journal of Pediatrics 96278–279. [DOI] [PubMed] [Google Scholar]
  • 42.Rossignol JF, Ayoub A, Ayers MS.(2001)Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. Journal of Infectious Diseases 184103–106. [DOI] [PubMed] [Google Scholar]
  • 43.Saha DR, Rajendran K, Ramamurthy T, Nandy RK, Bhattacharya SK.(2008)Intestinal parasitism and Vibrio cholerae infection among diarrhoeal patients in Kolkata, India. Epidemiology and Infection 136661–664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Savioli L, Smith H, Thompson A.(2006)Giardia and Cryptosporidium join the ‘Neglected Disease Initiative’. Trends in Parasitology 22203–208. [DOI] [PubMed] [Google Scholar]
  • 45.Scott KG, Meddings JB, Kirk DR, Lees-Miller SP, Buret AG.(2002)Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology 1231179–1190. [DOI] [PubMed] [Google Scholar]
  • 46.Snel SJ, Baker MG, Venugopal K.(2009)The epidemiology of giardiasis in New Zealand, 1997–2006. New Zealand Medical Journal 12262–75. [PubMed] [Google Scholar]
  • 47.Thompson RC.(2000)Giardiasis as a re-emerging infectious disease and its zoonotic potential. International Journal for Parasitology 301259–1267. [DOI] [PubMed] [Google Scholar]
  • 48.Veronesi S, Palmerio B, Negosanti M, Tosti A.(1983)Urticaria and giardiasis. Dermatológica 16642–43. [DOI] [PubMed] [Google Scholar]
  • 49.Wolfe M.(1992)Giardiasis. Clinical Microbiology Reviews 593–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Yakoob J, Jafri W, Abid S, Jafri N, Hamid S, Shah HA, Rizvi L, Islam M, Shaikh H.(2005)Giardiasis in patients with dyspeptic symptoms. World Journal of Gastroenterology 116667–6670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Yoder JS, Beach MJ.(2007)Giardiasis surveillance — United States, 2003–2005. Morbidity and Mortality Weekly Report. Surveillance Summaries 5611–18. [PubMed] [Google Scholar]
  • 52.Younas M, Shah S, Talaat A.(2008)Frequency of Giardia lamblia infection in children with recurrent abdominal pain. Journal of Pakistan Medical Association 58171–174. [PubMed] [Google Scholar]
  • 53.Zeyrek D, Zeyrek F, Cakmak A, Cekin A.(2008)Association of Helicobacter pylori and giardiasis in children with recurrent abdominal pain. Turkiye Parazitolojii Dergisi 324–7. [PubMed] [Google Scholar]

Articles from Annals of Tropical Medicine and Parasitology are provided here courtesy of Maney Publishing

RESOURCES